Amenamevir

N/A

Report date: 2022/01/14 13:23:58
NMEFirst In Class

Base Information

Drug NameAmenamevir
Drug Alias Nameamenamevir阿那美韦amenamevirum阿莫奈韦Amenalief +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA helicase/primase complex inhibitors
TargetsDNA helicase/primase complex
Therapy Area/IndicationsHerpes ZosterHerpes SimplexHerpes Genitalis
Global Approved IndicationsHerpes Zoster
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2017/07/03
Country/TerritoryUnited StatesUnited KingdomFrance +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesMaruho Co Ltd
Active IndicationsHerpes Zoster
Inactive IndicationsHerpes SimplexHerpes Genitalis

Other Information

ATC CodeJ05AX26
Related LinksDrugBankKEGG